I-VFR do not usually request HA prior to travelling, basic due to considering it unnecessary. When they do request it, they are very often initially directed to their Family Doctor.
This article analyzes how the writer and publisher Carlos Barral (Barcelona, 1928–89) talks about his relationship with the Catalan language in many of his autobiographical texts. Examining the close connections that Barral establishes between Catalan and masculinity, I argue that the relationship between language and masculine models is essential for Barral in explaining why Spanish—and not Catalan—was the language in which he chose to write. Barral associates Catalan with his childhood, an important language needed to understand the self and closely related to Calafell, a small town situated on the Catalan coast where he spent time as a child. Catalan is also the language of the father and the fishermen from Calafell, men Barral considered role models during his childhood but who disappeared as he grew up. The article considers how Barral’s choosing Castilian over Catalan as a literary language and as the language of his publishing business is explained in the author’s texts as related to the disappearance of the father and the fishermen of Calafell, popular men who vanish in favor of the bourgeois and urban intellectuals who are Barral’s literary colleagues of the generación de medio siglo and who also wrote in Spanish. With this analysis, I aim to highlight how, in Carlos Barral’s texts, linguistic subjectivity is constructed vis-à-vis ideas of class and gender and how certain personal and libidinal elements are presented as essential in explaining Barral’s decision to use Spanish as a literary language.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.